Department of Pharmacology, Calcutta Institute of Pharmaceutical Technology & AHS, Uluberia, Howrah, 711316, West Bengal, India.
Naunyn Schmiedebergs Arch Pharmacol. 2024 Nov;397(11):8189-8209. doi: 10.1007/s00210-024-03188-3. Epub 2024 Jun 4.
Reactive oxygen species (ROS) are metabolic by-products that constitute an indispensable component of physiological processes, albeit their heightened presence may proffer substantial perils to biological entities. Such a proliferation gives rise to a gradual escalation of oxidative stress within the organism, thereby compromising mitochondrial functionality and inflicting harm upon various bodily systems, with a particular predilection for the central nervous system. In its nascent stages, it is plausible that inflammation has been a facilitator in the progression of the malady. The precise role of inflammation in Alzheimer's disease (AD) remains somewhat enigmatic, although it is conceivable that activated microglia and astrocytes might be implicated in the removal of amyloid-β (Aβ) deposits. Nonetheless, prolonged microglial activation is associated with Tau phosphorylation and Aβ aggregation. Research studies have indicated that AD brains upregulate complementary molecules, inflammatory cytokines, acute phase reacting agents, and other inflammatory mediators that may cause neurodegeneration. In this review, oxidative damage products will be discussed as potential peripheral biomarkers for AD and its early stages. The disordered excretion of pro-inflammatory cytokines, chemokines, oxygen, and nitrogen-reactive species, along with the stimulation of the complement system by glial cells, has the potential to disrupt the functionality of neuronal termini. This perturbation, in turn, culminates in compromised synaptic function, a phenomenon empirically linked to the manifestation of cognitive impairments. The management of neurodegenerative conditions in the context of dementia necessitates therapeutic interventions that specifically target the excessive production of inflammatory and oxidative agents. Furthermore, we shall deliberate upon the function of microglia and oxidative injury in the etiology of AD and the ensuing neurodegenerative processes.
活性氧(ROS)是代谢副产物,是生理过程中不可或缺的组成部分,尽管它们的存在可能会对生物实体造成巨大的危险。这种增殖会导致生物体中氧化应激的逐渐加剧,从而损害线粒体功能,并对各种身体系统造成伤害,特别是对中枢神经系统。在疾病的早期阶段,炎症可能是疾病进展的促进因素。炎症在阿尔茨海默病(AD)中的确切作用仍然有些神秘,尽管可以想象激活的小胶质细胞和星形胶质细胞可能与清除淀粉样蛋白-β(Aβ)沉积有关。然而,长期的小胶质细胞激活与 Tau 磷酸化和 Aβ 聚集有关。研究表明,AD 大脑上调互补分子、炎症细胞因子、急性期反应剂和其他炎症介质,这些物质可能导致神经退行性变。在这篇综述中,氧化损伤产物将被讨论为 AD 及其早期阶段的潜在外周生物标志物。炎性细胞因子、趋化因子、氧和氮反应性物质的紊乱排泄,以及神经胶质细胞对补体系统的刺激,有可能破坏神经元末端的功能。这种干扰反过来又导致突触功能受损,这一现象与认知障碍的表现有经验上的联系。在痴呆症背景下对神经退行性疾病的管理需要针对炎症和氧化剂过度产生的治疗干预。此外,我们将讨论小胶质细胞和氧化损伤在 AD 发病机制和随后的神经退行性过程中的作用。